Amgen data files lawsuit against Regeneron, Sanofi to prevent infringing manufacture of alirocumab Amgen today announced that it filed a lawsuit in the United States , and Regeneron Pharmaceuticals, Inc. for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which are owned by Amgen, explain and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 . By its complaint, Amgen seeks an injunction to avoid the infringing manufacture, use and sale of Sanofi and Regeneron's alirocumab, a monoclonal antibody targeting PCSK9.Hegemony. And, as the U.S. Deficit grows, the decline of the dollar becomes much more serious. Per CNBC, ‘For a country with a spending budget deficit in excess of $1 trillion a season, the results of losing standing as the world’s reserve currency would be dire.’ ‘The No. 1 security concern. ”If the dollar loses status as the world’s most reliable currency the United States will lose the proper to print money to pay its personal debt. It’ll be forced to spend this debt,’ Bove explained. ‘The rankings agencies already are arguing that the government’s debt could be too highly regarded. Plus, the United States Congress, in both its houses, as well as the president are demonstrating a complete insufficient fiscal credibility.’ The chat of financial recovery in the U.S., buoyed by a stock market setting record highs, provides pushed the problem of U.S.